Peripheral Neuropathy Trial, Recruiting (NCT07342777)

Peripheral Neuropathy Trial, Recruiting NCT07342777 Sponsor: University of Aarhus Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT07342777 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have an average pain level of more than 3 out of 10 on a standard pain scale
You are 18 years old or older
You have been officially diagnosed with Multiple Sclerosis (MS)
You are able to get yourself to the testing and exercise sessions independently

Who may not be able to join:

You are currently pregnant
You have diabetes
You have other neurological conditions or health issues that would make it difficult to take part in the study (confirm with trial site)
You have had an MS relapse (a flare-up of symptoms) in the past 2 months
You are considered to be at high risk for heart or cardiovascular problems, based on guidelines from the American College of Sports Medicine (confirm with trial site)
You have been doing regular, structured exercise in the past 3 months, meaning 2 or more sessions per week

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4593508304

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07342777

Sponsor: University of Aarhus

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: +4593508304

More information: https://clinicaltrials.gov/study/NCT07342777

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have an average pain level of more than 3 out of 10 on a standard pain scale
You are 18 years old or older
You have been officially diagnosed with Multiple Sclerosis (MS)
You are able to get yourself to the testing and exercise sessions independently

Who may not be able to join:

You are currently pregnant
You have diabetes
You have other neurological conditions or health issues that would make it difficult to take part in the study (confirm with trial site)
You have had an MS relapse (a flare-up of symptoms) in the past 2 months
You are considered to be at high risk for heart or cardiovascular problems, based on guidelines from the American College of Sports Medicine (confirm with trial site)
You have been doing regular, structured exercise in the past 3 months, meaning 2 or more sessions per week

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Aarhus

Registry

ClinicalTrials.gov

Start date

15 January 2026

Est. completion

1 July 2028

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Change in pain severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov